Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease portal vein thrombosis
Comorbidity C0863194|resectable hepatocellular carcinoma
Sentences 4
PubMedID- 26133576 Introduction: this study compares radioembolization ((90)y) versus doxorubicin drug eluting beads (debdox) in the treatment of unresectable hepatocellular carcinoma with portal vein thrombosis.
PubMedID- 21443089 Chemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis.
PubMedID- 21748824 Purpose: iodine-131-labeled lipiodol is currently licensed for unresectable hepatocellular carcinoma with portal thrombosis.
PubMedID- 25584161 Transarterial chemoembolization in unresectable hepatocellular carcinoma with portal vein thrombosis: a perspective on survival.

Page: 1